Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06335173
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-03-13
Brief Title:
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimers Disease ALTITUDE-AD
Sponsor:
Acumen Pharmaceuticals
Organization:
Acumen Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-29
Start Date Type:
ACTUAL
Primary Completion Date:
2031-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-13
First Submit QC Date:
March 21 2024
Study First Post Date:
2024-03-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-18
Last Update Post Date:
2024-07-10
Last Update Post Date Type:
ACTUAL